Garzon, V.; Salvador, J.-P.; Marco, M.-P.; G.-Pinacho, D.; Bustos, R.-H.
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics 2024, 13, 600.
https://doi.org/10.3390/antibiotics13070600
AMA Style
Garzon V, Salvador J-P, Marco M-P, G.-Pinacho D, Bustos R-H.
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics. 2024; 13(7):600.
https://doi.org/10.3390/antibiotics13070600
Chicago/Turabian Style
Garzon, Vivian, J.-Pablo Salvador, M.-Pilar Marco, Daniel G.-Pinacho, and Rosa-Helena Bustos.
2024. "Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach" Antibiotics 13, no. 7: 600.
https://doi.org/10.3390/antibiotics13070600
APA Style
Garzon, V., Salvador, J. -P., Marco, M. -P., G.-Pinacho, D., & Bustos, R. -H.
(2024). Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach. Antibiotics, 13(7), 600.
https://doi.org/10.3390/antibiotics13070600